Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhende Medical CoSHSE:603301 -3.46%53 Gross Margin % is 34.60% as of Jun. 2026, which is 2% above its 10-year median of 33.97. GuruFocus rates SHSE:603301 with a GF Score™ of 53/100 and a GF Value™ of ¥26.63 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Zhende Medical Co ranks worse than 76.37% on this metric.
Zhende Medical Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -4.8%.
The historical rank and industry rank for Zhende Medical Co's Gross Margin % or its related term are showing as below:
SHSE:603301'
s Gross Margin % Range Over the Past 10 Years
Min: 29.59 Med: 33.97 Max: 46.97
Current: 34.13
During the past 12 years, the highestGross Margin % of Zhende Medical Co was 46.97%. The lowest was 29.59%. And the median was 33.97%.
SHSE:603301's Gross Margin % is ranked worse than 76.37% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 52.44
vs SHSE:603301: 34.13
Zhende Medical Co had a gross margin of 34.60% for the quarter that ended in Jun. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Zhende Medical Co was -4.80% per year.
Zhende Medical Co (SHSE:603301) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Zhende Medical Co had a gross margin of 34.60% for the quarter that ended in Jun. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Zhende Medical Co Gross Margin % Related Terms
Zhende Medical Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Zhende Medical Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603301 vs ISRG, BDX, RMD: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Zhende Medical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhende Medical Co Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zhende Medical Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Zhende Medical Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Zhende Medical Co (SHSE:603301) has a Gross Margin % of 34.60% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Zhende Medical Co and its competitors. This is near median its historical median of 33.97. Over the past decade, Zhende Medical Co's Gross Margin % has ranged from 29.59 to 46.97. According to the industry distribution chart, Zhende Medical Co ranks #614 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 76.4%.
Is Zhende Medical Co's Gross Margin % too high?
Zhende Medical Co's current Gross Margin % of 34.60% is near median its 10-year median of 33.97. Over the past 10 years, this metric has ranged from a low of 29.59 to a high of 46.97. The Medical Devices & Instruments industry median Gross Margin % is 52.44. Zhende Medical Co's value of 34.60% is 34% below this industry median. Based on the distribution chart, Zhende Medical Co ranks #614 out of 804 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Zhende Medical Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhende Medical Co's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Zhende Medical Co ranks #614 out of 804 companies for Gross Margin %. This places Zhende Medical Co in the lower half of its industry. The industry median Gross Margin % is 52.44. Zhende Medical Co's value of 34.60% is 34% below this benchmark. Historically, Zhende Medical Co's own Gross Margin % has ranged from 29.59 to 46.97 over the past decade. While the company's 10-year median is 33.97 vs. the industry median of 52.44, Zhende Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.44, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhende Medical Co's current Gross Margin % of 34.60% is 34% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Zhende Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhende Medical Co's current Gross Margin % is 34.60%, which is near median its own 10-year median of 33.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhende Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhende Medical Co (SHSE:603301) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥26.63, compared to a current price of ¥81.24 — trading 205.1% above its estimated fair value. The current Gross Margin % is 34.60%, which is near median its 10-year median of 33.97 and 34% below the Medical Devices & Instruments industry median of 52.44. Zhende Medical Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Zhende Medical Co (SHSE:603301), the current Gross Margin % is 34.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhende Medical Co (SHSE:603301) Overvalued in 2026?
Based on GuruFocus' analysis, Zhende Medical Co stock appears to be overvalued.
The current stock price of ¥81.24 is trading 205.1% above its estimated GF Value™ of ¥26.63.
GuruFocus considers Zhende Medical Co to be Significantly Overvalued.
Key valuation signals for SHSE:603301:
Gross Margin %: 34.60% (near median its 10-year median of 33.97)
GF Value™: ¥26.63 vs. price of ¥81.24 (205.1% above fair value)
Industry Position: 34% below the Medical Devices & Instruments median (#614 of 804)
No single metric tells the full story. See the SHSE:603301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhende Medical Co Ltd operates as a supplier of medical care and protection in China. The company is engaged in the production and sales of medical dressings. Its product categories are basic medical dressings, operating room sensory control, pressure therapy and fixation, stoma and chronic wounds, Isolation protection, and personal protection.
53GF Score
Get the complete analysis for SHSE:603301
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603301 has been successfully added to your 
